F2 and cancer: Compared to the AF stroke and cancer control groups, patients in the cancer stroke group had lower platelet counts, and prolonged prothrombin time/international normalized ratio (PT/INR) and activated partial thromboplastin time (aPTT) (p < 0.001 for all cases) (Table 1).